Conference Coverage (Retrovirus)
Naked-DNA HIV Vaccine Safe in First Human Trials
Published in Vaccine Weekly, February 17th, 1997
The vaccine is being developed by a research team led by David B. Weiner of the University of Pennsylvania in collaboration with Apollon Inc., Malvern, Pennsylvania. Weiner's group has received a four-year, $4.2 million grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) to develop naked DNA for use as an AIDS therapy.
The so-called naked DNA vaccine consists of a gene construct, pM160-MN, that expresses the envelope glycoprotein of the MN strain of HIV-1 under the control of the human cytomegalovirus (CMV) promoter gene. The DNA...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-02-17)
More Articles from Vaccine Weekly
- Conference Coverage (Hepatitis)
Therapeutic Vaccines Offer Promise for Chronic HBV - Conference Coverage (Retrovirus)
Disappointing Results With Vaccine/AZT Combination - Conference Coverage (Retrovirus)
New Tricks For Old Vaccine - Conference Coverage (Retrovirus)
Routine Vaccination Does Not Affect HIV - Acellular Pertussis
Vaccine Recommendations for Use in Infants Applauded - Breast Cancer
Cooperative Research Efforts Announced To Develop Vaccine - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
